Lineage Cell Therapeutics (LCTX) Gross Margin (2011 - 2025)
Lineage Cell Therapeutics (LCTX) recorded Gross Margin of 97.60% in Q1 2025, up 4.39 percentage points from 93.21% a year earlier and up 2.97 percentage points from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Gross Margin (2011 - 2025) Analysis & Trends
On a TTM basis, Lineage Cell Therapeutics' Gross Margin came in at 97.15% as of Mar 31, 2025, up 5.28 percentage points year-over-year; for FY2024, it was 96.48%, up 3.99 percentage points from FY2023.
- Annual Gross Margin has a five-year change of +8.21 percentage points (FY2019 to FY2024).
- Across earlier years, Gross Margin came in at 92.50% in FY2023 (-2.55 pp), 95.05% in FY2022 (+27.90 pp), 67.15% in FY2021 (-11.77 pp) and 78.92% in FY2020 (-9.36 pp).
- Quarterly Gross Margin has ranged from 56.61% in Q3 2021 to 98.99% in Q3 2024 over the past five years.
- On a year-over-year basis, Gross Margin has increased for four consecutive quarters, with an average year-over-year change of +1.37 percentage points over the last eight quarters.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 35.55 percentage points in Q3 2022, against a drop of 25.53 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 94.63% (Q4 2024), 98.99% (Q3 2024) and 96.88% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 97.60% |
| Dec 31, 2024 | 94.63% |
| Sep 30, 2024 | 98.99% |
| Jun 30, 2024 | 96.88% |
| Mar 31, 2024 | 93.21% |
| Dec 31, 2023 | 87.74% |
| Sep 30, 2023 | 86.44% |
| Jun 30, 2023 | 96.06% |
| Mar 31, 2023 | 95.01% |
| Dec 31, 2022 | 94.67% |
| Sep 30, 2022 | 92.16% |
| Jun 30, 2022 | 95.28% |
| Mar 31, 2022 | 96.64% |
| Dec 31, 2021 | 82.53% |
| Sep 30, 2021 | 56.61% |
| Jun 30, 2021 | 75.59% |
| Mar 31, 2021 | 71.36% |
| Dec 31, 2020 | 67.89% |
| Sep 30, 2020 | 82.14% |
| Jun 30, 2020 | 80.57% |
API Access
Lineage Cell Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();